As you all are aware of, thrombosis (coronary, cerebral and venous) accounted for two of three deaths in 2010 (Lancet 2012; 380:2095-128). Prevention and treatment of thromboembolic events is, therefore, a main issue in medicine that involves all the components of health care system. Recently, a strong boost in this field came from the introduction of new antithrombotic agents whose use is expanding with the need for more information by real-life studies. Thus, ICT is an important venue to compare clinical experiences and learn new advances in basic and pharmacological sciences. The meeting has the aim to prepare unique scientific program based on lectures, presentations, discussion and‘ Pros’ and ‘cons’ debates.
Also, this conference offers the opportunity for 6 young (< 40) investigators - the ones with the highest abstract score-) to have full access to a major symposium as invited speakers by having travel, accommodation and registration entirely covered by the organization.